IL85145A - תכשירים רוקחיים או וטירינריים אנטי-מטאסטטים המכילים הרפין ששונה בעל פיעילות אנטי קרישתית מופחתת - Google Patents

תכשירים רוקחיים או וטירינריים אנטי-מטאסטטים המכילים הרפין ששונה בעל פיעילות אנטי קרישתית מופחתת

Info

Publication number
IL85145A
IL85145A IL8514588A IL8514588A IL85145A IL 85145 A IL85145 A IL 85145A IL 8514588 A IL8514588 A IL 8514588A IL 8514588 A IL8514588 A IL 8514588A IL 85145 A IL85145 A IL 85145A
Authority
IL
Israel
Prior art keywords
heparin
cells
activity
metastatic
anticoagulant activity
Prior art date
Application number
IL8514588A
Other languages
English (en)
Original Assignee
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Australian filed Critical Univ Australian
Priority to IL10635488A priority Critical patent/IL106354A/he
Priority to IL106354A priority patent/IL106354A0/xx
Publication of IL85145A publication Critical patent/IL85145A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL8514588A 1987-01-23 1988-01-20 תכשירים רוקחיים או וטירינריים אנטי-מטאסטטים המכילים הרפין ששונה בעל פיעילות אנטי קרישתית מופחתת IL85145A (he)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL10635488A IL106354A (he) 1987-01-23 1988-01-20 תכשירי רוקחות או תכשירים וטירינרייםהמכילים פוקוידן או הפרין ששונה לטיפול אנטי -דלקתי
IL106354A IL106354A0 (en) 1987-01-23 1993-07-15 Pharmaceutical or veterinary compositions containing a sulfated polysaccharide for anti-inflammatory treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPH999187 1987-01-23

Publications (1)

Publication Number Publication Date
IL85145A true IL85145A (he) 1994-08-26

Family

ID=3771996

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8514588A IL85145A (he) 1987-01-23 1988-01-20 תכשירים רוקחיים או וטירינריים אנטי-מטאסטטים המכילים הרפין ששונה בעל פיעילות אנטי קרישתית מופחתת

Country Status (8)

Country Link
EP (2) EP0631784B1 (he)
JP (2) JP2701904B2 (he)
AT (2) ATE178212T1 (he)
CA (1) CA1316828C (he)
DE (2) DE3856321T2 (he)
IL (1) IL85145A (he)
SG (2) SG45156A1 (he)
WO (1) WO1988005301A1 (he)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
CA2102207A1 (en) * 1991-05-02 1992-11-03 Irun R. Cohen Compositions for the prevention and/or treatment of patholigical processes
US5861382A (en) * 1992-05-01 1999-01-19 Yeda Research And Development Co. Ltd. Methods for regulation of active TNF-α
US6750207B1 (en) 1992-05-01 2004-06-15 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
IT1264709B1 (it) * 1993-07-12 1996-10-04 Italfarmaco Spa Derivati eparinici ad attivita' antimetastatica
JP3403496B2 (ja) * 1993-09-24 2003-05-06 株式会社ヤクルト本社 抗潰瘍剤およびヘリコバクター・ピロリの定着阻害剤
US5739115A (en) * 1993-10-07 1998-04-14 Glycomed Incorporated Sulfated maltooligosaccharides with heparin-like properties
EP0722326A4 (en) * 1993-10-07 1999-10-06 Glycomed Inc HIGHLY SULFATED MALTOOLIGOSSACCHARIDES WITH HEPARIN-LIKE PROPERTIES
FR2718024B1 (fr) * 1994-03-30 1996-06-21 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement de l'inflammation.
US5783568A (en) * 1994-06-10 1998-07-21 Sugen, Inc. Methods for treating cancer and other cell proliferative diseases
ATE273020T1 (de) 1995-09-29 2004-08-15 Biomarin Pharm Inc Verwendung von heparinasen zur verminderung von entzündungsreaktionen
AU1042597A (en) * 1995-12-18 1997-07-14 Stichting Sanquin Bloedvoorziening Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
KR100555845B1 (ko) * 1996-01-26 2006-11-23 다카라 홀딩스 인크. 항암제
JP3505185B2 (ja) * 1996-06-12 2004-03-08 タカラバイオ株式会社 食品又は飲料
US7151099B2 (en) 1998-07-31 2006-12-19 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Use of taurolidine and/or taurultam for treatment of abdominal cancer and/or for the prevention of metastases
US8304390B2 (en) 1997-07-31 2012-11-06 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of treatment for preventing or reducing tumor growth in the liver of patient
US8030301B2 (en) 1999-06-04 2011-10-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of cancers with methylol-containing compounds and at least one electrolyte
US7892530B2 (en) 1999-06-04 2011-02-22 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
US7345039B2 (en) 1999-06-04 2008-03-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
ATE367166T1 (de) * 1999-08-20 2007-08-15 Takara Bio Inc Heilmittel
US6641571B2 (en) 2000-01-05 2003-11-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery
EP1381620B1 (en) 2001-04-16 2006-03-22 Ivax Research, Inc. Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
CZ307433B6 (cs) 2001-09-12 2018-08-22 Leadiant Biosciences Sa Deriváty částečně desulfátovaných glykosaminoglykanů jako inhibitory heparanázy mající antiangiogenní účinky a zabraňující antikoagulačnímu působení
US7285536B2 (en) 2001-12-05 2007-10-23 Yeda Research And Development Co., Ltd. Anti-cancer therapeutic compounds
ITMI20021294A1 (it) * 2002-06-12 2003-12-12 Inalco Spa Polisaccaridi batterici o-solfatati e loro uso
US20050186645A1 (en) 2003-12-18 2005-08-25 Yehudit Amor Method for analyzing a glycomolecule
PL1748781T3 (pl) 2004-05-27 2013-05-31 Baxter Int Sposoby do leczenia zaburzeń związanych z krwawieniem z zastosowaniem siarczanowanych polisacharydów
JP5701498B2 (ja) * 2009-12-01 2015-04-15 公益財団法人微生物化学研究会 炎症性細胞からのヘパラナーゼの放出抑制剤、抗炎症剤、及び薬用組成物
JP5934735B2 (ja) * 2014-03-28 2016-06-15 株式会社オプトクリエーション ナノバブル・フコイダン水素水
NL2024493B1 (en) * 2019-12-16 2021-09-02 Logick Energetics B V Pharmaceutical composition for preventing or stopping metastases
EP4076439A1 (en) * 2019-12-18 2022-10-26 Logick Energetics Pharmaceutical composition for use in preventing or stopping metastases
WO2022265510A1 (en) * 2021-06-17 2022-12-22 Logick Energetics B.V. Pharmaceutical composition for use in the treatment of metastatic epithelial ovarian cancer, metastatic fallopian tube carcinoma or metastatic primary peritoneal carcinoma

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1730M (fr) * 1962-01-17 1963-03-18 Charles Riviere Nouvelle composition de collyre.
JPS5943929B2 (ja) * 1979-08-13 1984-10-25 サッポロビール株式会社 多糖体ｒｂｓ物質，その製法およびそれを有効成分とする抗腫瘍性剤
DE3373782D1 (en) * 1982-12-20 1987-10-29 Harvard College Inhibition of angiogenesis
AU555747B2 (en) * 1983-08-09 1986-10-09 Cilco Inc. Chondroitin sulfate and sodium hyaluronate composition
FR2553287B1 (fr) * 1983-10-18 1986-09-12 Choay Sa Compositions a base de mucopolysaccharides ou d'oligosaccharides, notamment a base de fractions ou fragments d'heparine, appropriees au traitement de desordres de la proliferation cellulaire
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
US4710493A (en) * 1984-08-14 1987-12-01 Albert Landsberger Therapeutic agent for the use in cancer treatment
FR2584606A1 (fr) * 1985-07-12 1987-01-16 Dropic Utilisation de poly- et oligosaccharides pour l'obtention de medicaments actifs dans les pathologies du tissu conjonctif
IL79255A0 (en) * 1986-06-26 1986-09-30 Hadassah Med Org Composition for metastasis prevention
IL79254A0 (en) * 1986-06-26 1986-09-30 Hadassah Med Org Compositions for preventing graft rejection
EP0356435B1 (en) * 1987-03-19 1995-10-18 Arthropharm Pty. Limited Anti-inflammatory compounds and compositions
JPH06157520A (ja) * 1992-11-13 1994-06-03 Kirin Brewery Co Ltd 新規物質ｈｑ２４

Also Published As

Publication number Publication date
JPH09328431A (ja) 1997-12-22
DE3856321T2 (de) 1999-08-26
ATE178212T1 (de) 1999-04-15
JPH02502006A (ja) 1990-07-05
CA1316828C (en) 1993-04-27
EP0355088B1 (en) 1997-12-10
SG52246A1 (en) 1998-09-28
EP0355088A4 (en) 1990-06-26
EP0631784A1 (en) 1995-01-04
EP0355088A1 (en) 1990-02-28
DE3856321D1 (de) 1999-05-06
WO1988005301A1 (en) 1988-07-28
DE3856083D1 (de) 1998-01-22
HK1014153A1 (en) 1999-09-24
DE3856083T2 (de) 1998-07-02
ATE160941T1 (de) 1997-12-15
SG45156A1 (en) 1998-01-16
EP0631784B1 (en) 1999-03-31
JP2752353B2 (ja) 1998-05-18
JP2701904B2 (ja) 1998-01-21

Similar Documents

Publication Publication Date Title
US5541166A (en) Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
CA1316828C (en) Compounds having anti-metastatic and/or anti-inflammatory activity
Coombe et al. Analysis of the inhibition of tumour metastasis by sulphated polysaccharides
Laurent et al. Hyaluronan 1
EP0583360B1 (en) Compositions for the prevention and/or treatment of pathological processes
US8058344B2 (en) Glycodendrimers having biological activity
US4687765A (en) Method and composition for thrombolytic treatment
WO2013095215A1 (en) Low anticoagulant heparins
US8524688B2 (en) Use of sulfated glycosaminoglycans for establishing effective labor in women
Dziarski Enhancement of mixed leukocyte reaction and cytotoxic antitumor responses by heparin.
AU605839B2 (en) Compounds having anti-metastatic and/or anti-inflammatory activity
AU605839C (en) Compounds having anti-metastatic and/or anti-inflammatory activity
Sakuma et al. Suppressive effect of prostaglandin E1 on pulmonary hypertension induced by monocrotaline in rats
IL106354A (he) תכשירי רוקחות או תכשירים וטירינרייםהמכילים פוקוידן או הפרין ששונה לטיפול אנטי -דלקתי
KR100249442B1 (ko) 스트렙토코커스아갈락티아에ia형또는ib형표면다당을주성분으로하는암전이저해제
CN101267828A (zh) 用于共同递送抗癌药、抗血管生成药和多糖的组合物及方法
WO2005013884A2 (en) Methods for preventing neurological events
JPH0818993B2 (ja) プロスタグランジンｉ▲下２▼産生増強剤
CN117940136A (zh) 具有抗癌特性的低分子量he800外泌多糖衍生物及其用途
Didisheim et al. Drugs and the prevention of thrombosis in shunts
JP2004002239A (ja) ＴＮＦ−α産生抑制剤
JP2004513060A (ja) 器官保護溶液

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees